Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Clarify Medication Orders for Hospice Resident

Bolingbrook, Illinois Survey Completed on 06-11-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A resident with multiple complex medical conditions, including heart failure, diabetes, hypertension, repeated falls, hallucinations, and severe cognitive impairment, was admitted to the facility for a hospice respite stay following a fall at home. Upon admission, there were two separate medication lists for the resident: one from the local hospital emergency room and another from the hospice provider. The facility did not document any communication with the hospice provider to clarify which medication list should be followed during the resident's stay. As a result, the resident received several medications that were not included on the hospice provider's medication list, such as atorvastatin, carvedilol, cholestyramine aspartame, and potassium chloride. These medications were administered over multiple days during the resident's stay, despite the hospice provider's list specifying a different regimen. The facility's Director of Nursing and staff did not contact the physician or hospice provider to resolve the discrepancy between the hospital and hospice medication lists. Interviews with facility staff and the hospice nurse confirmed that the facility should have clarified the appropriate medication regimen, especially since the resident was under hospice care. The facility's own policy required coordination with hospice providers regarding medication information, but this protocol was not followed, leading to the administration of unnecessary medications.

An unhandled error has occurred. Reload 🗙